175 related articles for article (PubMed ID: 37935889)
1. Impact of metabolic dysfunction-associated fatty liver disease on liver transplant recipients with hepatitis B virus-related hepatocellular carcinoma.
Zhu JQ; Ye XY; Yang SW; Liu JZ; Ren ZY; Jia YN; Liu Z; Ding C; Kou JT; Li XL; Han DD; He Q
Eur J Clin Nutr; 2024 Feb; 78(2):107-113. PubMed ID: 37935889
[TBL] [Abstract][Full Text] [Related]
2. Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma.
Zhu JQ; Liu JZ; Yang SW; Ren ZY; Ye XY; Liu Z; Li XL; Han DD; He Q
Front Endocrinol (Lausanne); 2024; 15():1306091. PubMed ID: 38686208
[TBL] [Abstract][Full Text] [Related]
3. Effect of ethnicity on liver transplant for hepatocellular carcinoma.
Couto CA; Gelape CL; Calmet F; Martin P; Levy C
Exp Clin Transplant; 2013 Aug; 11(4):339-45. PubMed ID: 23905912
[TBL] [Abstract][Full Text] [Related]
4. The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma.
Lu D; Yang F; Zhuo J; Yang M; Lin Z; Jin P; Cai X; Cen B; Wang J; Wei X; Zheng S; Xu X
Clin Transl Gastroenterol; 2020 May; 11(5):e00168. PubMed ID: 32358239
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
[TBL] [Abstract][Full Text] [Related]
6. Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010.
Hu Z; Zhou J; Wang H; Zhang M; Li S; Huang Y; Wu J; Li Z; Zhou L; Zheng S
PLoS One; 2013; 8(4):e61620. PubMed ID: 23613886
[TBL] [Abstract][Full Text] [Related]
7. Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.
Zhang M; Li B; Yan LN; Yin F; Wen TF; Zeng Y; Zhao JC; Ma YK
World J Gastroenterol; 2008 Feb; 14(8):1280-5. PubMed ID: 18300358
[TBL] [Abstract][Full Text] [Related]
8. Liver Transplantation Outcomes of HBV-, HCV-, and Alcohol-induced Hepatocellular Carcinoma in the United States: Analysis of National Inpatient Samples.
Zhang SS; Zhang JF; Wang JQ; Tang J; Wu ZL; Huang J; Xue J
Curr Med Sci; 2023 Jun; 43(3):520-525. PubMed ID: 37115395
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study.
Xiong J; Wang J; Huang J; Sun W; Wang J; Chen D
Clinics (Sao Paulo); 2015 Aug; 70(8):563-8. PubMed ID: 26247669
[TBL] [Abstract][Full Text] [Related]
10. A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma.
Hernandez-Alejandro R; Croome KP; Drage M; Sela N; Parfitt J; Chandok N; Marotta P; Dale C; Wall W; Quan D
World J Gastroenterol; 2012 Aug; 18(31):4145-9. PubMed ID: 22919246
[TBL] [Abstract][Full Text] [Related]
11. Impact of hepatitis B surface antigen positive grafts on liver transplantation in patients with benign and malignant liver disease.
Yu J; Shi X; Yu H; Wu J; Ma J; Dong S; Lu S; Zheng S; Li L; Xu X; Cao H
J Med Virol; 2022 Jul; 94(7):3338-3348. PubMed ID: 35257389
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
13. Rapid fibrosis and significant histologic recurrence of hepatitis C after liver transplant is associated with higher tumor recurrence rates in hepatocellular carcinomas associated with hepatitis C virus-related liver disease: a single center retrospective analysis.
Vasavada BB; Chan CL
Exp Clin Transplant; 2015 Feb; 13(1):46-50. PubMed ID: 25654412
[TBL] [Abstract][Full Text] [Related]
14. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B.
Huang SC; Su TH; Tseng TC; Chen CL; Hsu SJ; Liao SH; Hong CM; Liu CH; Lan TY; Yang HC; Liu CJ; Chen PJ; Kao JH
Hepatol Int; 2023 Oct; 17(5):1139-1149. PubMed ID: 37247045
[TBL] [Abstract][Full Text] [Related]
15. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
Ahn SY; Kim SB; Song IH
Can J Gastroenterol Hepatol; 2020; 2020():4873875. PubMed ID: 32566546
[TBL] [Abstract][Full Text] [Related]
16. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
[TBL] [Abstract][Full Text] [Related]
17. A case report of de novo hepatocellular carcinoma after living donor liver transplantation.
Yu S; Guo H; Zhuang L; Yu J; Yan S; Zhang M; Wang W; Zheng S
World J Surg Oncol; 2013 Aug; 11(1):176. PubMed ID: 23915066
[TBL] [Abstract][Full Text] [Related]
18. Association Between ACOX1 and NRF1 Gene Expression and Hepatitis B and C Virus Infections and Hepatocellular Carcinoma in Liver Transplant Patients (Shiraz, Iran).
Abdolyousefi EN; Motalleb G; Yaghobi R
Exp Clin Transplant; 2022 Jan; 20(1):52-58. PubMed ID: 34763625
[TBL] [Abstract][Full Text] [Related]
19. Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B.
van Kleef LA; Choi HSJ; Brouwer WP; Hansen BE; Patel K; de Man RA; Janssen HLA; de Knegt RJ; Sonneveld MJ
JHEP Rep; 2021 Oct; 3(5):100350. PubMed ID: 34557660
[TBL] [Abstract][Full Text] [Related]
20. Impact of donor age on liver transplant outcomes in patients with hepatocellular carcinoma: analysis of the SRTR database.
Zhou J; Huang Z; Chen Z; Xu F; Tong R; Zheng S
BMC Gastroenterol; 2021 Apr; 21(1):195. PubMed ID: 33931011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
